The company will gain a novel oral treatment for lung cancer
Source: PMLiVE
You may also like
EC approves Erbitux combination for first‑line...
FDA approves Leqembi Iqlik subcutaneous initiation...
Novel Epigenetic Therapy Targets Treatment-Resistant...
FDA Issues Proposal to Streamline Registration for...
Cellares and Sonoma Biotherapeutics Agree to Automate...
Genome-Scale CRISPRi Atlas Maps Gene Function Across...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.